Skip to content

Antiphospholipid Syndrome in elevated blood pressure and small babies in pregnancy

Antiphospholipid Syndrome in Pre-eclampsia with severe features and fetal growth restriction.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050483
Enrollment
100
Registered
2023-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O098- Supervision of other high risk pregnancies Health Condition 2: O098- Supervision of other high risk pregnancies

Interventions

None listed

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Singleton pregnancy women delivered at or before 36 weeks gestation Preeclampsia with severe features and/or Fetal growth restriction due to placental Insufficiency.

Exclusion criteria

Exclusion criteria: Multiple gestations

Design outcomes

Primary

MeasureTime frame
Antiphospholipid syndrome positivity in cases and controls.Timepoint: positivity in cases. positivity in controls.

Secondary

MeasureTime frame
Positivity of Single and multiple lab criteria in patients with antiphospholipid syndrome.Timepoint: 1) single criteria positive 2) multiple criteria positive

Countries

India

Contacts

Public ContactDr Himakshi Boro

Maulana Azad Medical College

drsangeetamamc@gmail.com8368199481

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026